Citations

Citations to this article as recorded by  

• Clinicopathological significances of cribriform pattern in lung adenocarcinoma
  Jung-Soo Pyo, Byoung-Hoon Lee, Kyueng-Whan Min, Nae Yu Kim
  Pathology - Research and Practice.2024; 253: 155035.     CrossRef
• Clinicopathological features and prognostic significance of pulmonary adenocarcinoma with signet ring cell components: meta-analysis and SEER analysis
  Yang Tan, Ying-he Huang, Jia-wen Xue, Rui Zhang, Run Liu, Yan Wang, Zhen-Bo Feng
  Clinical and Experimental Medicine.2023; 23(8): 4341.     CrossRef
• Lung-Cancer Risk in Mice after Exposure to Gamma Rays, Carbon Ions or Neutrons: Egfr Pathway Activation and Frequent Nuclear Abnormality
  Kenshi Suzuki, Shunsuke Yamazaki, Ken-ichi Iwata, Yutaka Yamada, Takamitsu Morioka, Kazuhiro Daino, Mutsumi Kaminishi, Mari Ogawa, Yoshiya Shimada, Shizuko Kakinuma
  Radiation Research.2022;[Epub]     CrossRef
• Pathological cytomorphologic features and the percentage of ALK FISH-positive cells predict pulmonary adenocarcinoma prognosis: a prospective cohort study
  Fenge Jiang, Congcong Wang, Ping Yang, Ping Sun, Jiannan Liu
  World Journal of Surgical Oncology.2021;[Epub]     CrossRef
• Cribriform pattern in lung invasive adenocarcinoma correlates with poor prognosis in a Chinese cohort
  Yang Qu, Haifeng Lin, Chen Zhang, Kun Li, Haiqing Zhang
  Pathology - Research and Practice.2019; 215(2): 347.     CrossRef
• Incidence of brain metastasis in lung adenocarcinoma at initial diagnosis on the basis of stage and genetic alterations
  Bumhee Yang, Hyun Lee, Sang-Won Um, Kyunga Kim, Jae Il Zo, Young Mog Shim, O Jung Kwon, Kyung Soo Lee, Myung-Ju Ahn, Hojoong Kim
  Lung Cancer.2019; 129: 28.     CrossRef
• Qualitative and quantitative cytomorphological features of primary anaplastic lymphoma kinase‐positive lung cancer
  Ryuko Tsukamoto, Hiroyuki Ohsaki, Sho Hosokawa, Yasunori Tokuhara, Shingo Kamoshida, Toshiko Sakuma, Tomoo Itoh, Chiho Ohbayashi
  Cytopathology.2019; 30(3): 295.     CrossRef
• Double Trouble: A Case Series on Concomitant Genetic Aberrations in NSCLC
  Nele Van Der Steen, Yves Mentens, Marc Ramael, Leticia G. Leon, Paul Germonpré, Jose Ferri, David R. Gandara, Elisa Giovannetti, Godefridus J. Peters, Patrick Pauwels, Christian Rolfo
  Clinical Lung Cancer.2018; 19(1): 35.     CrossRef
• Update on the potential significance of psammoma bodies in lung adenocarcinoma from a modern perspective
  Akio Miyake, Koji Okudela, Mai Matsumura, Mitsui Hideaki, Hiromasa Arai, Shigeaki Umeda, Shoji Yamanaka, Yoshihiro Ishikawa, Michihiko Tajiri, Kenichi Ohashi
  Histopathology.2018; 72(4): 609.     CrossRef
• Integrin β3 Inhibition Enhances the Antitumor Activity of ALK Inhibitor in ALK-Rearranged NSCLC
  Ka-Won Noh, Insuk Sohn, Ji-Young Song, Hyun-Tae Shin, Yu-Jin Kim, Kyungsoo Jung, Minjung Sung, Mingi Kim, Sungbin An, Joungho Han, Se-Hoon Lee, Mi-Sook Lee, Yoon-La Choi
  Clinical Cancer Research.2018; 24(17): 4162.     CrossRef
• An anaplastic lymphoma kinase-positive lung cancer microlesion: A case report
  Tetsuo Kon, Youichiro Baba, Ichiro Fukai, Gen Watanabe, Tomoko Uchiyama, Tetsuya Murata
  Human Pathology: Case Reports.2017; 7: 11.     CrossRef
• The prevalence of ALK rearrangement in pulmonary adenocarcinomas in an unselected Caucasian population from a defined catchment area: impact of smoking
  Birgit G Skov, Paul Clementsen, Klaus R Larsen, Jens B Sørensen, Anders Mellemgaard
  Histopathology.2017; 70(6): 889.     CrossRef
• Ciliated muconodular papillary tumor of the lung harboring ALK gene rearrangement: Case report and review of the literature
  Yan Jin, Xuxia Shen, Lei Shen, Yihua Sun, Haiquan Chen, Yuan Li
  Pathology International.2017; 67(3): 171.     CrossRef
• Molecular breakdown: a comprehensive view of anaplastic lymphoma kinase (ALK)‐rearranged non‐small cell lung cancer
  Ka‐Won Noh, Mi‐Sook Lee, Seung Eun Lee, Ji‐Young Song, Hyun‐Tae Shin, Yu Jin Kim, Doo Yi Oh, Kyungsoo Jung, Minjung Sung, Mingi Kim, Sungbin An, Joungho Han, Young Mog Shim, Jae Ill Zo, Jhingook Kim, Woong‐Yang Park, Se‐Hoon Lee, Yoon‐La Choi
  The Journal of Pathology.2017; 243(3): 307.     CrossRef
• Anaplastic lymphoma kinase immunohistochemistry in lung adenocarcinomas: Evaluation of performance of standard manual method using D5F3 antibody
  D Jain, K Jangra, PS Malik, S Arulselvi, K Madan, S Mathur, MC Sharma
  Indian Journal of Cancer.2017; 54(1): 209.     CrossRef
• Clinicopathological Features and Therapeutic Responses of Chinese Patients with Advanced Lung Adenocarcinoma Harboring an Anaplastic Lymphoma Kinase Rearrangement
  Danxia Lin, De Zeng, Chen Chen, Xiao Wu, Miaojun Wang, Jiongyu Chen, Hui Lin, Xihui Qiu
  Oncology Research and Treatment.2017; 40(1-2): 27.     CrossRef
• A Validation Study for the Use of ROS1 Immunohistochemical Staining in Screening for ROS1 Translocations in Lung Cancer
  Patrizia Viola, Manisha Maurya, James Croud, Jana Gazdova, Nadia Suleman, Eric Lim, Tom Newsom-Davis, Nick Plowman, Alexandra Rice, M. Angeles Montero, David Gonzalez de Castro, Sanjay Popat, Andrew G. Nicholson
  Journal of Thoracic Oncology.2016; 11(7): 1029.     CrossRef
• Non-small Cell Lung Cancer with Concomitant EGFR, KRAS, and ALK Mutation: Clinicopathologic Features of 12 Cases
  Taebum Lee, Boram Lee, Yoon-La Choi, Joungho Han, Myung-Ju Ahn, Sang-Won Um
  Journal of Pathology and Translational Medicine.2016; 50(3): 197.     CrossRef
• ALK gene rearranged lung adenocarcinomas: molecular genetics and morphology in cohort of patients from North India
  Amanjit Bal, Navneet Singh, Parimal Agarwal, Ashim Das, Digambar Behera
  APMIS.2016; 124(10): 832.     CrossRef